- Home
- RDZN vs SGMO Comparison
RDZN vs SGMO Comparison
Compare RDZN & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDZN | SGMO |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.7M | 135.1M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | RDZN | SGMO |
|---|---|---|
| Price | $1.89 | $0.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.60 |
| AVG Volume (30 Days) | 220.1K | ★ 4.3M |
| Earning Date | 02-11-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $48,035,296.00 | $32,875,000.00 |
| Revenue This Year | $40.39 | N/A |
| Revenue Next Year | $64.09 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.42 | N/A |
| 52 Week Low | $0.68 | $0.37 |
| 52 Week High | $2.56 | $1.40 |
Technical Indicators
Market Signals| Indicator | RDZN | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 36.49 |
| Support Level | $1.82 | $0.37 |
| Resistance Level | $1.96 | $0.41 |
| Average True Range (ATR) | 0.17 | 0.03 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 18.94 | 12.36 |
Price Performance
Historical ComparisonAbout RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.